Dipanjan Debnath, MD, is joining Zeeshan Ahmad, MD; Paul M. Brager, MD; Salman S. Osman, MD; and Ather Syed, MD, at UHC Oncology, coming from Allegheny Health Network Cancer Institute in Pittsburgh, Pa.
Dr. Debnath’s educational journey began with a Bachelor of Medicine and Surgery (MBBS) from the Armed Forces Medical College, Pune, India.
He went on to his residency in Internal Medicine at MedStar Georgetown University Washington Hospital Center, Washington, DC. His fellowship at AHN Cancer Institute was in hematology and oncology. His area of interest includes plasma cell disorders, lymphoid malignancies and breast cancer.
His contributions to professional publications have been extensive as has his involvement in presentations at medical meetings. Among his writings, Dr. Debnath has published research on immunotherapy in pancreatic cancer and the effects of electronic cigarettes on the gastrointestinal system, with his work garnering several citations.
He is board certified in internal medicine and board eligible in medical oncology and hematology. Professional organizations in which he is a member include American College of Physicians, American Society of Hematology and American Society of Clinical Oncology.
Dr. Debnath’s office is located at 327 Medical Park Drive, in Bridgeport. Please visit uhcwv.com or call 681-342-1800 for more information.
